About: Mitozolomide

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Mitozolomide (INN) is an antineoplastic. It is an derivative. Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.

Property	Value
dbo:abstract	Mitozolomide (INN) is an antineoplastic. It is an derivative. Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide. (en)
dbo:casNumber	85622-95-3
dbo:chEMBL	435951
dbo:fdaUniiCode	E3U7286V3W
dbo:pubchem	71766
dbo:thumbnail	wiki-commons:Special:FilePath/Mitozolomide.svg?width=300
dbo:wikiPageID	21261240 (xsd:integer)
dbo:wikiPageLength	2956 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1021676498 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Abandoned_drugs dbc:Organochlorides dbr:Antineoplastic dbr:Clinical_trial dbc:Carboxamides dbr:International_Nonproprietary_Name dbr:Temozolomide dbc:Imidazotetrazines dbr:Analog_(chemistry) dbr:Myelosuppression dbr:Imidazotetrazine
dbp:atcPrefix	none (en)
dbp:c	7 (xsd:integer)
dbp:casNumber	85622 (xsd:integer)
dbp:chembl	435951 (xsd:integer)
dbp:chemspiderid	64805 (xsd:integer)
dbp:cl	1 (xsd:integer)
dbp:h	7 (xsd:integer)
dbp:iupacName	3 (xsd:integer)
dbp:n	6 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:pubchem	71766 (xsd:integer)
dbp:smiles	NCc1ncn2CN\N=N/c12 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	QXYYYPFGTSJXNS-UHFFFAOYSA-N (en)
dbp:unii	E3U7286V3W (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	376147382 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:width	210 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Chemotherapeutic_agents dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Stdinchicite
dcterms:subject	dbc:Abandoned_drugs dbc:Organochlorides dbc:Carboxamides dbc:Imidazotetrazines
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Agent114778436 yago:Antineoplastic102722458 yago:CausalAgent100007347 yago:CytotoxicDrug103157987 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090 yago:WikicatExperimentalCancerDrugs umbel-rc:DrugProduct
rdfs:comment	Mitozolomide (INN) is an antineoplastic. It is an derivative. Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide. (en)
rdfs:label	Mitozolomide (en)
owl:sameAs	freebase:Mitozolomide yago-res:Mitozolomide wikidata:Mitozolomide dbpedia-sh:Mitozolomide dbpedia-sr:Mitozolomide https://global.dbpedia.org/id/4rv2C
prov:wasDerivedFrom	wikipedia-en:Mitozolomide?oldid=1021676498&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Mitozolomide.svg
foaf:isPrimaryTopicOf	wikipedia-en:Mitozolomide
is dbo:wikiPageWikiLink of	dbr:Alkylating_antineoplastic_agent dbr:Chemotherapy dbr:List_of_drugs:_Meu–Mi
is foaf:primaryTopic of	wikipedia-en:Mitozolomide